Location History:
- The Woodlands, TX (US) (1997)
- Malvern, PA (US) (1997 - 2001)
Company Filing History:
Years Active: 1997-2001
Title: Innovations of Hector Wasunna Alila
Introduction
Hector Wasunna Alila is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of biotechnology, particularly in the area of growth hormone activity. With a total of 4 patents to his name, Alila's work has the potential to impact various agricultural and medical applications.
Latest Patents
One of Alila's latest patents is titled "Immunogenic compositions that potentiate growth hormone activity." This invention relates to immunogenic compositions capable of enhancing growth hormone activity. It comprises an immunologically effective amount of a composite peptide that includes at least two non-contiguous somatotropin epitope amino acid sequences. Importantly, this composite peptide is substantially free of receptor binding domain sequences and is combined with an immunologically acceptable excipient. The invention also outlines methods for using this immunogenic composition to enhance the action of growth hormone in pigs.
Another significant patent is "Fused somatotropin epitopic peptides that potentiate growth hormone." This invention involves composite somatotropin peptides that include somatotropin epitopic amino acid sequences, along with fusion proteins that are useful in enhancing growth hormone activity. The patent also discloses vectors and host cells that are beneficial for the recombinant production of these molecules. Additionally, vaccines containing the composite somatotropin peptides and fusion proteins are described, along with methods for their application.
Career Highlights
Hector Wasunna Alila is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with other talented professionals in the field, contributing to innovative solutions in biotechnology.
Collaborations
Some of Alila's notable coworkers include Michael Thomas Clark and Elaine V Jones. Their collaborative efforts have likely played a role in advancing the research and development of new biotechnological applications.
Conclusion
Hector Wasunna Alila's contributions to the field of biotechnology, particularly through his patents related to growth hormone activity, demonstrate his innovative spirit and dedication to scientific advancement. His work has the potential to influence both agricultural practices and medical treatments, showcasing the importance of innovation in improving health and productivity.